Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.190
-0.070 (-5.56%)
At close: May 18, 2026, 4:00 PM EDT
1.240
+0.050 (4.20%)
After-hours: May 18, 2026, 5:31 PM EDT

Telomir Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
5.567.291.2700-
Cash & Short-Term Investments
5.567.291.2700-
Cash Growth
1279.78%475.51%102753.78%-13.25%--
Accounts Receivable
---0.13--
Other Current Assets
0.230.050.060.30.1-
Total Current Assets
5.797.341.320.440.1-
Other Long-Term Assets
---4.34--
Total Assets
5.797.341.324.770.05-
Accounts Payable
0.280.540.590.710.40.02
Accrued Expenses
-0.42----
Short-Term Debt
0.2--0.1--
Other Current Liabilities
0.340.470.090.530.580.12
Total Current Liabilities
0.831.430.681.340.990.14
Total Liabilities
0.831.430.681.340.990.14
Additional Paid-in Capital
46.9646.9231.2417.50.060
Retained Earnings
-42-41.01-30.6-14.06-0.99-0.14
Shareholders' Equity
4.965.910.643.44-0.94-0.14
Total Liabilities & Equity
5.797.341.324.770.050
Total Debt
0.2000.100
Net Cash (Debt)
5.367.291.27-0.10-0
Net Cash Growth
-26.47%475.51%----
Net Cash Per Share
0.160.230.04-0.00--
Book Value
4.965.910.643.44-0.94-0.14
Book Value Per Share
0.150.190.020.13-0.03-0.06
Tangible Book Value
4.965.910.643.44-0.94-0.14
Tangible Book Value Per Share
0.150.190.020.13-0.03-0.06
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q